Wu-Chou Su
8PUBLICATIONS
73CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 29, 2025
Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma.Shubham Pant, Joon Oh Park, Wu-Chou Su
|Apr 16, 2025
Deubiquitinase USP24 activated by IL-6/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response.Hung-Chia Hsieh, Ming-Jer Young, Kuan-Yu Chen
|Sep 09, 2024
Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer.Chun-Hua Hung, Shang-Yin Wu, Cheng-I Daniel Yao
|May 22, 2024
IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer.You-En Yang, Meng-Hsuan Hu, Yen-Chen Zeng
|Oct 20, 2022
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON.Ryan J Hartmaier, Aleksandra A Markovets, Myung Ju Ahn
|Sep 21, 2022
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan.Li-Hsin Chien, Tzu-Yu Chen, Chung-Hsing Chen
Pageof 2
Frequent Collaborators
3 joint publications
Yi-Ching Wang
2 joint publications
Chien-Chung Lin
1 joint publications
Po-Lan Su
1 joint publications
Li-Hsin Chien
1 joint publications
Tzu-Yu Chen
1 joint publications
Chung-Hsing Chen
1 joint publications
Kuan-Yu Chen
1 joint publications
Chin-Fu Hsiao
1 joint publications
Gee-Chen Chang
1 joint publications
Ying-Huang Tsai
